Biology Reference
In-Depth Information
Schofield, D. J., Bartosch, B., Shimizu, Y. K., Allander, T., Alter, H. J., Emerson, S. U., Cosset, F. L.,
and Purcell, R. H. (2005). Human monoclonal antibodies that react with the E2 glycoprotein of
hepatitis C virus and possess neutralizing activity. Hepatology 42, 1055-1062.
Schornberg, K., Matsuyama, S., Kabsch, K., Delos, S., Bouton, A., and White, J. (2006). Role of
endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174-4178.
Schulz, T. F., Jameson, B. A., Lopalco, L., Siccardi, A. G., Weiss, R. A., and Moore, J. P. (1992).
Conserved structural features in the interaction between retroviral surface and transmembrane
glycoproteins? AIDS Res. Hum. Retroviruses 8, 1571-1580.
Sessions, O. M., Barrows, N. J., Souza-Neto, J. A., Robinson, T. J., Hershey, C. L., Rodgers, M. A.,
Ramirez, J. L., Dimopoulos, G., Yang, P. L., Pearson, J. L., and Garcia-Blanco, M. A. (2009).
Discovery of insect and human dengue virus host factors. Nature 458, 1047-1050.
Shah, P. P., Myers, M. C., Beavers, M. P., Purvis, J. E., Jing, H., Grieser, H. J., Sharlow, E. R.,
Napper, A. D., Huryn, D. M., Cooperman, B. S., Smith, A. B., 3rd, and Diamond, S. L. (2008).
Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding
inhibitor of human cathepsin L.
Mol. Pharmacol. 74, 34-41.
Shah, P. P., Wang, T., Kaletsky, R. L., Myers, M. C., Purvis, J. E., Jing, H., Huryn, D. M.,
Greenbaum, D. C., Smith, A. B., 3rd, Bates, P., and Diamond, S. L. (2010). A small-molecule
oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola
pseudotype virus infection into human embryonic kidney 293T cells.
Mol. Pharmacol.
78,
319-324.
Shimojima, M., Takada, A., Ebihara, H., Neumann, G., Fujioka, K., Irimura, T., Jones, S.,
Feldmann, H., and Kawaoka, Y. (2006). Tyro3 family-mediated cell entry of Ebola and Marburg
viruses.
J. Virol. 80, 10109-10116.
Shimojima, M., Ikeda, Y., and Kawaoka, Y. (2007). The mechanism of Axl-mediated Ebola virus
infection.
J. Infect. Dis. 196(Suppl. 2), S259-S263.
Shmulevitz, M., and Duncan, R. (2000). A new class of fusion-associated small transmembrane
(FAST) proteins encoded by the non-enveloped fusogenic reoviruses. EMBO J. 19, 902-912.
Sieczkarski, S. B., and Whittaker, G. R. (2002). Dissecting virus entry via endocytosis. J. Gen. Virol.
83, 1535-1545.
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., and Bates, P. (2005).
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl.
Acad. Sci. USA 102, 11876-11881.
Sinn, P. L., Hickey, M. A., Staber, P. D., Dylla, D. E., Jeffers, S. A., Davidson, B. L., Sanders, D. A.,
and McCray, P. B., Jr. (2003). Lentivirus vectors pseudotyped with filoviral envelope glycopro-
teins transduce airway epithelia from the apical surface independently of folate receptor alpha.
J. Virol. 77, 5902-5910.
Sitbon, M., d'Auriol, L., Ellerbrok, H., Andre, C., Nishio, J., Perryman, S., Pozo, F., Hayes, S. F.,
Wehrly, K., Tambourin, P.,
. (1991). Substitution of leucine for isoleucine in a sequence
highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the
Friend murine leukemia virus.
et al
Proc. Natl. Acad. Sci. USA 88, 5932-5936.
Skehel, J. J., and Wiley, D. C. (2000). Receptor binding and membrane fusion in virus entry: the
influenza hemagglutinin.
Annu. Rev. Biochem. 69, 531-569.
Song, C., Dubay, S. R., and Hunter, E. (2003). A tyrosine motif in the cytoplasmic domain of mason-
pfizer monkey virus is essential for the incorporation of glycoprotein into virions.
J. Virol. 77,
5192-5200.
Spies, C. P., Ritter, G. D., Jr., Mulligan, M. J., and Compans, R. W. (1994). Truncation of the
cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the
conformation of the external domain.
J. Virol. 68, 585-591.
Stadler, K., Allison, S. L., Schalich, J., and Heinz, F. X. (1997). Proteolytic activation of tick-borne
encephalitis virus by furin.
J. Virol. 71, 8475-8481.
